Mainz Biomed BV
NASDAQ:MYNZ
Mainz Biomed BV
NASDAQ:MYNZ
Price:
1.11
USD
-1.77%
Market Cap:
$9.5m
Cash Flow Statement
Cash Flow Statement
Mainz Biomed BV
Mainz Biomed BV
Currency: USD
| Dec-2021 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net Income |
(12)
|
(26)
|
(33)
|
(41)
|
(47)
|
(26)
|
(23)
|
(22)
|
(19)
|
|
| Depreciation & Amortization |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
6
|
10
|
11
|
12
|
13
|
4
|
3
|
1
|
1
|
|
| Other Non-Cash Items |
9
|
10
|
11
|
12
|
13
|
4
|
3
|
3
|
3
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
1
|
1
|
3
|
1
|
(0)
|
(1)
|
0
|
(1)
|
|
| Cash from Operating Activities |
(3)
N/A
|
(15)
-359%
|
(20)
-38%
|
(26)
-25%
|
(32)
-24%
|
(22)
+31%
|
(19)
+12%
|
(17)
+11%
|
(15)
+10%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
|
| Other Items |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
1
N/A
|
(1)
N/A
|
(2)
-212%
|
(2)
-6%
|
(2)
-6%
|
(2)
+17%
|
(1)
+58%
|
(0)
+75%
|
(0)
-15%
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
10
|
24
|
26
|
26
|
26
|
6
|
5
|
14
|
17
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
4
|
9
|
9
|
7
|
3
|
(0)
|
|
| Other |
0
|
0
|
(0)
|
0
|
(1)
|
(1)
|
0
|
0
|
(0)
|
|
| Cash from Financing Activities |
11
N/A
|
24
+126%
|
25
+3%
|
30
+22%
|
35
+16%
|
14
-59%
|
11
-26%
|
17
+57%
|
17
+1%
|
|
| Change in Cash | ||||||||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Change in Cash |
9
N/A
|
8
-2%
|
2
-75%
|
2
+3%
|
1
-49%
|
(10)
N/A
|
(10)
+1%
|
(1)
+92%
|
1
N/A
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
(3)
N/A
|
(15)
-376%
|
(22)
-46%
|
(28)
-23%
|
(34)
-23%
|
(24)
+30%
|
(20)
+16%
|
(17)
+14%
|
(16)
+9%
|
|
Switch to:
Switch to:
See Also
Discover More
